Graham G. Walmsley

Average Profitability
20.1%
Insider Buys Quantity
17
Insider Buys Sum
$143.03M
Insider Sells Quantity
3
Insider Sells Sum
$26.91M

Insider Activity of Graham G. Walmsley

According to the SEC Form 4 filings, Graham G. Walmsley, being in a position of

  1. director at Akero Therapeutics, Inc.,
    оver the last 12 months, has bought 200000 shares for $9.6M, and sold 0 shares,
    over all time since 2022-09-19, has bought 1400000 shares for $42.53M, and sold 0 shares.

The largest purchase of all time was on 2020-11-23 and amounted to 2320000 shares of Olema Pharmaceuticals, Inc. for $44.08M.

The largest sale of all time was on 2024-06-04 and amounted to 1175000 shares of Olema Pharmaceuticals, Inc. for $17.45M.

Biography of Graham G. Walmsley

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Prismo
Buys
 $19,060,274350
Sells
 $26,909,024350

Comparison of Insiders on Amount of Buys and Sells

Prismo
Prismo
2025-01-30PurchaseAkero Therapeutics, Inc.
AKRO
director
200,000
0.2547%
$48.00$9.6M-10.93%
2024-12-17SaleOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.3522%
$6.75$4.73M-12.21%
2024-12-17PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.3522%
$6.75$4.73M-12.21%
2024-12-13SaleOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.2508%
$6.75$4.73M-18.52%
2024-12-13PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.2508%
$6.75$4.73M-18.52%
2024-06-04SaleOlema Pharmaceuticals, Inc.
OLMA
director
1.18M
2.2298%
$14.85$17.45M-18.05%
2023-12-08PurchaseAkero Therapeutics, Inc.
AKRO
director
100,000
0.179%
$19.83$1.98M+22.32%
2023-12-05PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
131,870
0.2639%
$14.19$1.87M-8.37%
2023-12-01PurchaseAkero Therapeutics, Inc.
AKRO
director
50,000
0.0866%
$16.99$849,730+36.75%
2023-11-30PurchaseAkero Therapeutics, Inc.
AKRO
director
50,000
0.0904%
$16.90$844,835+44.15%
2023-09-19PurchaseAkero Therapeutics, Inc.
AKRO
director
400,000
0.5235%
$26.00$10.4M-55.44%
2023-09-12PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
508,130
1.0101%
$9.84$5M+1.96%
2023-08-08PurchaseAkero Therapeutics, Inc.
AKRO
director
25,000
0.0442%
$42.06$1.05M-46.77%
2023-08-01PurchaseAkero Therapeutics, Inc.
AKRO
director
25,000
0.0453%
$43.26$1.08M-48.03%
2023-07-28PurchaseAkero Therapeutics, Inc.
AKRO
director
30,000
0.0645%
$42.69$1.28M-46.22%
2023-05-19PurchaseAkero Therapeutics, Inc.
AKRO
director
120,000
0.2354%
$42.00$5.04M-47.25%
2022-09-19PurchaseAkero Therapeutics, Inc.
AKRO
director
400,000
0.9981%
$26.00$10.4M+66.05%
2020-12-14PurchaseALX Oncology Holdings Inc.
ALXO
director
40,000
0.1009%
$76.00$3.04M-20.73%
2020-11-23PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
2.32M
4.1436%
$19.00$44.08M-44.3%
2020-07-21PurchaseALX Oncology Holdings Inc.
ALXO
director
1.95M
4.0591%
$19.00$37.05M+90.48%
Total: 20
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD